Fusion of Platelet Derived Growth Factor Receptor Alpha ( PDGFRA ) With Ubiquitin Specific Peptidase 8 ( USP8 ) in a Calcified Chondroid Mesenchymal Neoplasm Harboring t(4;15)(q12;q21) as a Sole Aberration.

Autor: Panagopoulos I; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; ioapan@ous-hf.no., Andersen K; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Gorunova L; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Lobmaier I; Department of Pathology, Oslo University Hospital, Oslo, Norway.

Publikováno v: Cancer genomics & proteomics [Cancer Genomics Proteomics] 2024 May-Jun; Vol. 21 (3), pp. 252-259.

Pathogenetic Dichotomy in Angioleiomyoma.

Autor: Panagopoulos I; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; ioannis.panagopoulos@rr-research.no., Andersen K; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Brunetti M; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Gorunova L; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Kostolomov I; Section for Applied Informatics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Kildal W; Section for Interphase Genetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Hognestad HR; Department of Pathology, Oslo University Hospital, Oslo, Norway., Lobmaier I; Department of Pathology, Oslo University Hospital, Oslo, Norway., Micci F; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Heim S; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.

Publikováno v: Cancer genomics & proteomics [Cancer Genomics Proteomics] 2023 Nov-Dec; Vol. 20 (6), pp. 556-566.

Recurrent 8q11-13 Aberrations Leading to PLAG1 Rearrangements, Including Novel Chimeras HNRNPA2B1::PLAG1 and SDCBP::PLAG1 , in Lipomatous Tumors.

Autor: Panagopoulos I; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; ioannis.panagopoulos@rr-research.no., Andersen K; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Gorunova L; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Lund-Iversen M; Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Lobmaier I; Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Micci F; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Heim S; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.

Publikováno v: Cancer genomics & proteomics [Cancer Genomics Proteomics] 2023 Mar-Apr; Vol. 20 (2), pp. 171-181.

Genomic Complexity as a Biomarker to De-Escalate Adjuvant Imatinib Treatment in High-Risk Gastrointestinal Stromal Tumor.

Autor: Boye K; Department of Oncology, Oslo University Hospital, Oslo, Norway., Gorunova L; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway., Gunawan B; Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany., Hompland I; Department of Oncology, Oslo University Hospital, Oslo, Norway., Sander B; Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany.; Institute of Pathology, Hannover Medical School, Hannover, Germany., Panagopoulos I; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway., Langer C; Clinic for General, Visceral, Thoracic and Minimally Invasive Surgery, Evangelical Hospital Göttingen-Weende, Göttingen, Germany., Golas M; Human Genetics, Faculty of Medicine, University of Augsburg, Augsburg, Germany.; Comprehensive Cancer Center Augsburg, University Medical Center Augsburg, Augsburg, Germany., Heim S; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Füzesi L; Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany.; Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Hølmebakk T; Department of Abdominal and Pediatric Surgery, Oslo University Hospital, Oslo, Norway., Micci F; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway.

Publikováno v: JCO precision oncology [JCO Precis Oncol] 2023 Feb; Vol. 7, pp. e2200351.

Fusion of the HMGA2 and BNC2 Genes in Uterine Leiomyoma With t(9;12)(p22;q14).

Autor: Panagopoulos I; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; ioannis.panagopoulos@rr-research.no., Andersen K; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Gorunova L; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Davidson B; Department of Pathology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Micci F; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Heim S; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Publikováno v: In vivo (Athens, Greece) [In Vivo] 2022 Nov-Dec; Vol. 36 (6), pp. 2654-2661.